• Affiliate Professor, Global Health
Phone Number: 
404-667-4473
Fax: 
Select from the following:
Biography 

Dr. Eve Lackritz has serves as the Acting Clinical Director of Rosebud Indian Health Service Hospital in South Dakota, providing oversight of clinical departments and the COVID-19 response. She formerly served with Doctors Without Borders in the Rohingya refugee camp in Bangladesh. Dr. Lackritz served at WHO-Geneva as the Zika Task Force Lead during the Zika pandemic, and the prior 4 years with the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS) at Seattle Children's, implementing a global research initiative to study upstream causes of preterm birth and vaccine safety monitoring in pregnancy in LMICs. Dr. Lackritz served the prior 23 years at the CDC in Atlanta, including Branch Chief of the Maternal and Infant Health Branch and in the Global AIDS Program. Her accomplishments included implementing the first national AIDS treatment programs in Africa, conducted clinical trials to prevent mother-to-child HIV transmission, and studied transmission of HHV-8. In CDC’s Malaria Branch, she investigated malaria, anemia, and child survival in Africa. Dr. Lackritz received her MD at Ohio State University and completed her pediatrics residency Case Western Reserve University.

Country Affiliations 
Languages 
  • French
Health Topics 
  • Arboviral Diseases
  • Child Mortality
  • COVID-19
  • Dengue
  • Epidemiology
  • Health Disparities
  • Immunizations
  • Infectious Diseases
  • Infectious Diseases (other than STDs)
  • Laboratory Strengthening
  • Maternal Child Health (incl. Reproductive Health)
  • Maternal Mortality
  • Zika
  • Zoonotic Diseases and Animal Health
DGH Centers, Programs and Initiatives and Affiliated Organizations 
Publications 

Lackritz EM, Wilson CB, Guttmacher AE, Howse JL, Engmann CM, Rubens CE, Mason EM, Muglia LJ, Gravett MG, Goldenberg RL, Murray JC, Spong CY, Simpson JL, the Preterm Birth Research Priority Setting Group. A solution pathway for preterm birth: accelerating a priority research agenda. Lancet Global Health 2013; 1(6):328-30. doi:10.1016/S2214-109X(13)70120-7.

Hladik H, Dollard SC, Mermin J, LaMonte A, Downing R, Amin R, Banage F, Nzaro E, Kataaha P, Dondero TJ, Pellett PE, Lackritz EM. Transmission of human herpsvirus 8 by blood transfusion. N Engl J Med 2006, 355:1331-8.

Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VS, Janssen RS, Notari EP,Lewis WF, Petersen LR. Estimated risk transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721-5.

Lackritz EM, Campbell CC, Ruebush TK, Hightower AW, Wakube W, Steketee RW, Were JBO. Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet 1992;340:524-8.